Liverpool’s prowess in lung health research has been recognised with the UK city named as host of the 47th Union World Conference on Lung Health in 2016.
The event is the premier annual international conference for researchers, health programme managers, policy experts, advocates and other leaders working to address tuberculosis, lung health and other global health issues primarily affecting people living in poverty. The conference, taking place at ACC Liverpool from October 25-29, 2016, is expected to draw more than 3,000 delegates from 125 countries and generate around £7.8m in economic benefit for Liverpool.
The conference is a key element of the work of the International Union Against Tuberculosis and Lung Disease (The Union), based in Paris, which draws from the best scientific expertise across 156 countries to advance health solutions to public health challenges. The World Conference’s five-day scientific programme will present the latest developments in the inter-related fights against tuberculosis, HIV, lung disease and non-communicable diseases.
Professor Bertie Squire, past president and board member of The Union and professor at Liverpool School of Tropical Medicine (LSTM), said: “The Union’s decision to host its World Conference in Liverpool is not only a recognition of our outstanding conference host city but also an acknowledgement of the leading research being conducted here in the field of TB and wider lung health.”
As well as being home to the Liverpool Heart and Chest Hospital, one of the largest specialist hospitals in the UK, the city is running The Liverpool Lung Project, the largest prospective population-based study in lung cancer in Europe and among the four major lung cancer studies world-wide. Funded by the Roy Castle Lung Cancer Foundation, hosted by the University of Liverpool, and led by Professor John K Field, the ground-breaking study aims to find out more about the causes of lung cancer and looks at ways of diagnosing lung cancer earlier. This includes identifying individuals who are at risk of the disease and developing new early lung cancer diagnostic biomarkers, with the research team at the forefront of molecular-genetic technologies.
José Luis Castro, executive director of The Union, said: “The World Conference is a critical opportunity for all those working on TB and other lung health issues to come together. I am delighted that the conference will be in Liverpool, where we have received such a warm welcome and where such great work in our field is taking place.”